AVR 1.67% $18.30 anteris technologies ltd

Aortic Vale publications form Berlin and Munich Hospitals, page-18

  1. 55 Posts.
    lightbulb Created with Sketch. 16
    thanks yes it does not make sense to me and the journals look like they are top class
    I have looked at the history on here since the current CEO took over and there appears to be so many gaps and he seems like a pharma guy not medical devices
    I also cant understand the blue sky proposition.
    any valve product would have to be at least 5 -10 years out and all the other competitors have years and years of patient experience with current products.
    I cant see Medtronic waiting around and waiting for Anteris. they would already be investing billions into their own valve technology.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.